Syngene International

Syngene International

635.15
+9.25
(1.48%)
Market Cap
25,220.00 Cr
EPS
12.35
PE Ratio
50.44
Dividend Yield
0.20 %
Industry
Healthcare
52 Week High
960.60
52 Week Low
599.55
PB Ratio
5.41
Debt to Equity
0.13
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from8 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+62.50 %
+62.50 %
Hold
Hold+12.50 %
+12.50 %
Sell
Sell+25.00 %
+25.00 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
635.15
#1 25,220.00
#3 50.44
#1 3,714.20
#4 3.77
#1 496
#5 14.53
39.84
547.35
13,018.90
#1 30.15
2,946.50
10.53
407
32.73
38.60
208.22
4,665.70
-
17.60
-46.34
-161
-83.93
27.17
653.85
2,965.20
48.02
322.30
0.22
41
#1 112.87
54.36
67.22
163.40
-
788.04
-22.39
-71
34.67
46.47
10.53
148.40
58.61
0.00
-65.97
37
76.32
54.40
38.35
60.60
493.63
46.84
8.04
0
-420.00
41.43
15.45
26.30
33.09
83.71
-3.26
2
-92.68
41.42
23.18
14.60
-
1.96
#1 40.00
-13
-566.67
36.99
Forecast
Actual
Growth Rate
Revenue Growth
3.77 %
Net Income Growth
-2.71 %
Cash Flow Change
12.04 %
ROE
-12.35 %
ROCE
-1.05 %
EBITDA Margin (Avg.)
-2.88 %

Quarterly Financial Results

Quarterly Financials
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
399
426
425
437
484
555
441
557
539
628
437
533
602
712
607
623
654
773
660
784
803
1,017
832
932
883
933
840
908
962
1,037
892
Expenses
262
280
297
292
327
374
300
325
366
403
297
364
408
443
430
464
438
508
472
552
555
680
596
663
626
600
620
646
660
674
668
EBITDA
138
146
128
145
158
181
142
231
174
225
140
170
193
269
177
160
216
265
188
232
248
337
236
268
257
333
220
261
302
363
224
Operating Profit %
33 %
32 %
27 %
30 %
30 %
30 %
29 %
30 %
30 %
34 %
30 %
30 %
30 %
33 %
28 %
24 %
32 %
33 %
27 %
28 %
29 %
32 %
26 %
27 %
27 %
35 %
22 %
27 %
30 %
34 %
24 %
Depreciation
35
34
37
40
43
44
47
53
57
62
66
69
70
70
75
76
79
80
86
90
95
96
102
105
108
111
107
111
109
106
111
Interest
5
7
8
8
8
8
7
8
10
9
7
7
7
7
8
1
9
6
9
12
14
10
11
13
11
13
12
13
12
16
12
Profit Before Tax
98
104
83
97
107
129
87
170
107
153
66
94
117
192
95
82
128
179
93
130
140
231
123
151
138
209
101
137
181
241
101
Tax
16
20
17
19
20
29
15
42
15
33
8
10
14
32
17
16
24
31
19
28
30
52
30
34
27
20
26
31
50
57
15
Net Profit
82
85
66
78
87
100
72
128
92
120
58
84
102
161
77
67
104
148
74
102
110
179
93
117
112
189
76
106
131
183
87
EPS in ₹
4.14
4.27
3.34
3.96
2.20
2.53
1.82
3.23
2.32
3.03
1.47
2.12
2.57
4.04
1.91
1.64
2.57
3.71
1.85
2.55
2.74
4.36
2.33
2.90
2.78
4.70
1.89
2.64
3.27
4.56
2.16

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
3,189
3,704
4,163
4,883
5,564
5,831
6,152
6,796
Fixed Assets
1,030
1,377
2,020
2,201
2,393
2,667
2,850
2,802
Current Assets
1,720
1,764
1,613
1,807
2,206
2,425
1,959
2,287
Capital Work in Progress
155
274
234
237
346
177
838
1,266
Investments
158
716
776
702
1,034
919
548
647
Other Assets
1,846
1,337
1,133
1,743
1,791
2,069
1,916
2,081
Total Liabilities
3,189
3,704
4,163
4,883
5,564
5,831
6,152
6,796
Current Liabilities
784
1,129
1,539
1,133
1,229
1,188
1,144
1,396
Non Current Liabilities
685
607
448
929
1,037
1,025
750
673
Total Equity
1,720
1,968
2,176
2,821
3,298
3,618
4,258
4,727
Reserve & Surplus
1,520
1,768
1,776
2,421
2,897
3,217
3,856
4,324
Share Capital
200
200
400
400
401
401
402
403

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
18
-88
28
130
-62
-172
-4
281
Investing Activities
-349
-646
-424
-629
-611
-653
-495
-744
Operating Activities
446
630
677
701
581
824
1,042
1,168
Financing Activities
-79
-72
-226
58
-31
-343
-551
-142

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
70.58 %
70.43 %
70.42 %
70.41 %
70.41 %
70.29 %
64.86 %
64.86 %
54.88 %
54.80 %
54.79 %
54.79 %
54.79 %
54.72 %
54.72 %
52.74 %
52.74 %
52.68 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.02 %
0.02 %
0.00 %
0.00 %
0.00 %
20.92 %
20.63 %
20.72 %
20.64 %
19.47 %
16.50 %
DIIs
4.02 %
3.81 %
4.03 %
3.64 %
3.26 %
2.79 %
4.96 %
7.04 %
10.73 %
11.20 %
9.94 %
13.08 %
15.80 %
16.80 %
17.48 %
19.53 %
21.50 %
24.05 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
8.05 %
8.29 %
8.46 %
9.20 %
9.22 %
9.02 %
8.81 %
8.57 %
8.39 %
8.10 %
7.53 %
7.24 %
6.45 %
6.08 %
5.45 %
5.59 %
5.08 %
5.59 %
Others
17.35 %
17.46 %
17.09 %
16.76 %
17.11 %
17.90 %
21.36 %
19.52 %
25.98 %
25.90 %
27.73 %
24.89 %
2.03 %
1.77 %
1.62 %
1.50 %
1.21 %
1.18 %
No of Share Holders
1,15,632
1,26,395
1,36,749
1,37,892
1,33,610
1,28,278
1,34,334
1,27,964
1,24,014
1,25,455
1,25,992
1,21,880
1,15,850
1,20,018
1,07,338
1,28,806
1,25,090
1,42,310

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 1 1 0.5 0.00 0.00 1 1.25 1.25 1.25
Dividend Yield (%) 0.00 0.33 0.34 0.21 0.00 0.00 0.17 0.18 0.17 0.2

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
12 Jun 2019 BONUS Bonus
1:1
11 Jun 2019 340.05 336.35
01 Jul 2022 DIVIDEND Dividend
₹ 0.50 /share
30 Jun 2022 627.50 554.75
01 Jul 2022 DIVIDEND Dividend
₹ 0.50 /share
30 Jun 2022 627.50 554.75
30 Jun 2023 DIVIDEND Dividend
₹ 0.75 /share
30 Jun 2023 625.90 759.60
30 Jun 2023 DIVIDEND Dividend
₹ 0.50 /share
30 Jun 2023 625.90 759.60
28 Jun 2024 DIVIDEND Dividend
₹ 1.25 /share
28 Jun 2024 701.05 713.15
24 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
24 Jul 2024 701.05 757.75
23 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Oct 2024 884.35 838.90
23 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jan 2025 859.80 828.15
23 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Apr 2025 697.45 735.45
27 Jun 2025 DIVIDEND Dividend
₹ 1.25 /share
27 Jun 2025 735.45 645.85
23 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jul 2025 634.20 676.25
23 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Jul 2025 735.45 676.25

Announcements

Grant Of Performance Share Units Under Syngene Long-Term Incentive Performance Share Plan 2023 (Plan)2 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation6 days ago
Announcement under Regulation 30 (LODR)-Change in ManagementAug 20, 2025
Intimation Of Cancellation Of Meeting With Analyst/Institutional InvestorAug 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 04, 2025
Grant Of Performance Share Units Under Syngene Long-Term Incentive Performance Share Plan 2023 (Plan)Aug 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 29, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 23, 2025
Intimation Of Change In Key Managerial Personnel (KMP) To Determine Materiality Of An Event Or InformationJul 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 23, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 23, 2025
Unaudited Financial Results For Quarter Ended June 30 2025.Jul 23, 2025
Board Meeting Outcome for Outcome Of The Board Meeting - July 23 2025Jul 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 19, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 17, 2025
Board Meeting Intimation for Board Meeting Intimation For Considering And Approving The Un-Audited Standalone And Consolidated Financial Results For The Quarter Ending June 30 2025.Jul 11, 2025
Grant Of Performance Share Units Under Syngene Long-Term Incentive Performance Share Plan 2023 (Plan)Jul 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJun 30, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 29, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jun 28, 2025
Reg. 34 (1) Annual Report.Jun 28, 2025
Notice Of 32Nd Annual General Meeting (AGM) Scheduled On Wednesday July 23 2025Jun 28, 2025
Closure of Trading WindowJun 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2025
Update On Inspection By United States Food & Drug Administration (USFDA)Jun 13, 2025
Intimation Of Resignation Letter Of Ms. Priyadarshini Mahapatra In Terms Of Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Jun 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 13, 2025
Receipt Of Establishment Inspection Report (EIR) By United States Food & Drug Administration (USFDA)Jun 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 11, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 06, 2025
Intimation Of Cancellation Of Meeting With Analyst/Institutional InvestorJun 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMay 29, 2025

Technical Indicators

RSI(14)
Neutral
39.84
ATR(14)
Less Volatile
16.86
STOCH(9,6)
Neutral
25.77
STOCH RSI(14)
Oversold
7.59
MACD(12,26)
Bearish
-5.23
ADX(14)
Weak Trend
17.80
UO(9)
Bearish
32.83
ROC(12)
Downtrend But Slowing Down
-2.13
WillR(14)
Neutral
-79.12

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
PGIM India Midcap Fund Direct-Growth
0.00%
-1727859
-0.95%
-1.31%
Franklin India Small Cap Fund Direct-Growth
0.57%
1100000
0.57%
0.57%
Mirae Asset Large & Midcap Fund Direct-Growth
0.71%
-1070478
-0.08%
-0.27%
Kotak Arbitrage Fund Direct-Growth
0.05%
-987000
-0.09%
-0.02%
SBI Arbitrage Opportunities Fund Direct-Growth
0.27%
957000
0.18%
0.18%
ICICI Prudential India Opportunities Fund Direct - Growth
0.14%
-944663
-0.19%
-0.21%
DSP Aggressive Hybrid Fund Direct-Growth
0.98%
877893
0.59%
0.98%
ICICI Prudential Innovation Fund Direct - Growth
1.16%
-743000
-0.55%
-0.63%
Franklin India Flexi Cap Fund Direct-Growth
0.27%
725000
0.27%
0.27%
DSP Top 100 Equity Direct Plan-Growth
1.21%
609060
0.73%
1.21%
Franklin India Multi Cap Fund Direct-Growth
0.83%
583923
0.83%
0.83%
HDFC Arbitrage Fund Wholesale Direct-Growth
0.20%
256000
0.10%
0.10%
Nippon India Small Cap Fund Direct- Growth
0.38%
254274
0.07%
0.13%
Tata Arbitrage Fund Direct - Growth
0.05%
-240000
-0.10%
0.05%
Nippon India Arbitrage Fund Direct-Growth
0.17%
227000
0.11%
0.11%
Tata India Pharma & Healthcare Fund Direct-Growth
1.58%
188949
1.05%
1.02%
Bandhan Arbitrage Fund Direct-Growth
0.34%
175000
0.17%
0.16%
ICICI Prudential Equity Arbitrage Direct-Growth
0.16%
175000
0.05%
0.04%
Mahindra Manulife Multi Cap Fund Direct - Growth
0.21%
170000
0.21%
0.21%
Mirae Asset Healthcare Fund Direct - Growth
0.56%
-150000
-0.31%
-1.19%
DSP Equity Savings Fund Direct-Growth
0.50%
149278
0.31%
0.50%
UTI Mid Cap Fund Direct-Growth
0.72%
149254
0.18%
0.14%
PGIM India Flexi Cap Fund Direct-Growth
0.78%
-125217
-0.03%
-0.06%
Mirae Asset Midcap Fund Direct - Growth
1.10%
-123725
0.08%
0.01%
Edelweiss Arbitrage Fund Direct-Growth
0.11%
-97000
-0.03%
-0.03%

About Syngene International

Syngene International Limited is an integrated research, development, and manufacturing services company headquartered in India. It serves global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The company operates across four business divisions: Discovery Services, Development Services, Manufacturing Services, and Dedicated Centers. With approximately 6000 scientists, Syngene has facilities spanning 2.2 million sq. ft. in Bangalore, Hyderabad, and Mangalore. It provides end-to-end services within Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO). Syngene offers various platforms and services including drug discovery, development capabilities, custom synthesis, process R&D, cGMP manufacturing, and clinical development services. The company has partnerships and collaborations with multiple global pharmaceutical and healthcare companies, expanding its research and manufacturing capabilities over the years.
Listing Date
11 Aug, 2015(10 Years, -9 days)
Chairperson NameKiran Mazumdar Shaw